Europe and MENA Generic Oncology Drug Market

Future Market Insights

Key Insight

The europe and mena generic oncology drug market is projected to grow from USD 7.0 billion in 2025 to USD 8.5 billion by 2035, at a CAGR of 2.0%. Small Molecule will dominate with a 61.4% market share, while oral will lead the route of administration segment with a 54.7% share.

September 29, 2025

Anurag Sharma

416 Pages

Cite this Report

Europe and MENA Generic Oncology Drug Market

https://www.futuremarketinsights.com/reports/generic-oncology-drug-industry-analysis-in-europe-and-mena

License

Buy Now

Summary ToC Companies

Key Players

Aqvida GmbH
Bayer
F. Hoffmann-La Roche Ag
GSK
Hikma Pharmaceuticals PLC
Lupin
L'Oréal
Sun Pharmaceutical Industries Ltd
Takeda Pharmaceutical Company Limited
Viatris Inc. (Mylan N.V)

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Europe and MENA Generic Oncology Drug Market

Key Players

Similar Industry Reports